Takaomi Taira

Recent progress in neurosurgical treatment of dystonias

Zbigniew Wszolek

Discovering the Genetic Causes of Parkinson Disease

Paolo Calabresi

Biomarkers

Petri Auvinen

Are microbiome changes important? - No

Jeffrey Boertien

Are microbiome changes important? - Yes

Mark Stacy

Physcial exercise is neurorestorative in Parkinson's disease: - No

Giuseppe Frazzitta

Physcial exercise is neurorestorative in Parkinson's disease: - Yes

Gesine Paul Visse

Growth factor infusions

Per Odin

Motor and non-motor effects of levodopa-carbidopa intestinal gel infusion

Marina Romero Ramos

Immune response in Parkinson disease : immunomodulation as a future therapeutic strategy

Ashley Pena

Myoclonus

Serge Przedborski

α-Synuclein and Mitochondria Associated Membrane protein

Roberto Cilia

Modifying gut microbiota is a promising treatment for Parkinson's disease. No

Fiorella Contarino

Modifying gut microbiota is a promising treatment for Parkinson's disease. Yes

Patrik Brundin

Is Alpha-Synuclein Still the Basis of Parkinson Disease?

Roongroj Bhidayasiri

Digital monitoring tools in Parkinson disease

Alberto J Espay

Biomarkers in biofluids

Wilma Van De Berg

Biomarkers in biofluids

Odile Van Den Heuvel

Multi-disciplinary approach to wearing off-related psychiatric symptoms

Tim Vanbellingen

Allied health update on fine motor skills in Parkinson disease

Elan Louis

What's new in tremor?

Marie Vidailhet

What's new in dystonia?

Christian Baumann

Noninvasive brain stimulation

Florin Gandor

Cannabinoids

Michael Schwarzschild

Repurposing strategies to prevent or slow Parkinson disease

Tove Henriksen

Update on apomorphine infusion

Peter Lewitt

Pros and cons of infusion therapies

Jinyoung Youn

Update on pathophysiology

Jorik Nonnekes

Personalized gait rehabilitation in Parkinson disease

Johannes De Munter

Autologous stem cell therapies